These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16454702)

  • 1. Chemokines in rheumatic diseases.
    Szekanecz Z; Szücs G; Szántó S; Koch AE
    Curr Drug Targets; 2006 Jan; 7(1):91-102. PubMed ID: 16454702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases.
    Bodolay E; Koch AE; Kim J; Szegedi G; Szekanecz Z
    J Cell Mol Med; 2002; 6(3):357-76. PubMed ID: 12417052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
    Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
    Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines and angiogenesis.
    Szekanecz Z; Koch AE
    Curr Opin Rheumatol; 2001 May; 13(3):202-8. PubMed ID: 11333349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological therapy of arthritis and systemic autoimmune diseases].
    Tamási L; Szekanecz Z
    Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis].
    Ingegnoli F; Manzo A; Fantini F; Caporali R; Montecucco C; Pipitone N; Pitzalis C
    Reumatismo; 2002; 54(1):12-8. PubMed ID: 12089609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rheumatic diseases in pregnancy].
    Märker-Hermann E; Bauer H; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
    Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z
    Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India.
    Chandrashekara S; Shobha V; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR
    Rheumatol Int; 2019 Mar; 39(3):497-507. PubMed ID: 30684040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort.
    Ciurea A; Papagiannoulis E; Bürki K; von Loga I; Micheroli R; Möller B; Rubbert-Roth A; Andor M; Bräm R; Müller A; Dan D; Kyburz D; Distler O; Scherer A; Finckh A
    Ann Rheum Dis; 2021 Feb; 80(2):238-241. PubMed ID: 32963052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines and chemokine receptors in rheumatoid arthritis.
    Szekanecz Z; Kim J; Koch AE
    Semin Immunol; 2003 Feb; 15(1):15-21. PubMed ID: 12495637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in rheumatic diseases: pathogenic role and therapeutic implications.
    Miyabe Y; Lian J; Miyabe C; Luster AD
    Nat Rev Rheumatol; 2019 Dec; 15(12):731-746. PubMed ID: 31705045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Henneken M; Dörner T; Burmester GR; Berek C
    Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocyte cytokines and rheumatic autoimmune disease.
    Youinou P; Taher TE; Pers JO; Mageed RA; Renaudineau Y
    Arthritis Rheum; 2009 Jul; 60(7):1873-80. PubMed ID: 19565509
    [No Abstract]   [Full Text] [Related]  

  • 15. Current perspective on rituximab in rheumatic diseases.
    Schioppo T; Ingegnoli F
    Drug Des Devel Ther; 2017; 11():2891-2904. PubMed ID: 29042750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.
    Winthrop KL; Weinblatt ME; Bathon J; Burmester GR; Mease PJ; Crofford L; Bykerk V; Dougados M; Rosenbaum JT; Mariette X; Sieper J; Melchers F; Cronstein BN; Breedveld FC; Kalden J; Smolen JS; Furst D
    Ann Rheum Dis; 2020 Jan; 79(1):88-93. PubMed ID: 31662322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
    Manolis AS; Tzioufas AG
    Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
    Yoon KH
    Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial chemokines in autoimmune disease.
    Christopherson KW; Hromas RA
    Curr Pharm Des; 2004; 10(2):145-54. PubMed ID: 14754394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared symptoms in rheumatic diseases: a blessing or a curse?
    Huizinga TW; Gröndal G
    Arthritis Rheum; 2009 Sep; 60(9):2547-9. PubMed ID: 19714580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.